← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 1, 2017Last known activity
Apr 30, 2020
Defunct as of Dec 31, 2025
Timeline
2010s
- Jun 1, 2015
Amygdala Neurosciences, Inc.— Founded
2020s
- Dec 31, 2025
Amygdala Neurosciences, Inc.— Defunct
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT04311294CollaboratorPhase 2Apr 30, 2020
- NCT03203499Study directorPhase 1Jul 1, 2017
- NCT03203499Lead sponsorPhase 1Jul 1, 2017
Details
- Founded
- Palo Alto, CA, US Jun 1, 2015
- Last known activity
- Apr 30, 2020